Enabling startups in digital health, medical technologies, and care programs to secure economic validation.
Demonstrate value, cost advantages, and cost-effectiveness to payers, investors, and healthcare systems.
Meeting economic validation standards secures adoption, reimbursement, and scalable market access.
What We Offer
Early Economic Assessment
We provide in-depth insights into the economic viability of new technologies. We analyze payer-user benefits to support market access evidence for innovative healthcare products and services.
Robust Health Economic Modelling
We offer customized health economic models to evaluate cost-effectiveness, budget impact, and value-based programs.
Helping clients make informed decisions and optimize their healthcare practices.
Reimbursement Submission
With a focus on payer requirements and regional regulations, Stepval develops reimbursement strategies that align with the benefits of new healthcare products and platforms.
Who We Are
Stepval is a health economics consulting boutique specializing in early-stage economic evaluation and health economic modeling for digital health solutions, medical devices, and personalized care programs.
Our differentiation lies in our therapeutic-area-specific service profiles, where internal domain experts engage at the earliest phase of client requests to deliver:
-
High-quality assessments aligned with payer and HTA requirements
-
Accelerated timelines through iterative model development
-
Efficiency gains via pre-validated analytic frameworks
Testimonials
"Stepval was great! Very responsive and quick without compromising quality"
A. Alnow, HTA director
Partners
Supported
by
